Chemokine receptor antagonists and methods of use therefor
US7541365B2 · kind B2 · utility
3Cited by
46References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 10, 2006 |
| Grant date | Jun 2, 2009 |
| Priority date | — |
| Expiry date | Nov 10, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by:or physiologically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.